🔥 Finally, our commentary on the problematic harm benefit ratio of escitalopram to treat pediatric generalized anxiety disorder is published. It took about 2 years and several rejections.
With @floriannaudet.bsky.social @joannamoncrieff.bsky.social @markhoro.bsky.social and John Warren
🧵 below
Subscription and open access journals from Sage, the world's leading independent academic publisher.
1/ What if a drug for anxiety disorder more likely makes you feel suicidal than help against anxiety? This was found for escitalopram in paediatric generalized anxiety disorder (GAD), but it was nonetheless approved. Let me explain and summarize experiences with trying to get this corrected in a🧵
